tiprankstipranks
LianBio double downgraded to Underperform at BofA ahead of ‘quiet 2024’
PremiumThe FlyLianBio double downgraded to Underperform at BofA ahead of ‘quiet 2024’
11M ago
LianBio downgraded to Underperform from Buy at BofA
Premium
The Fly
LianBio downgraded to Underperform from Buy at BofA
11M ago
Nanobiotix says LianBio enters NBTXR3 development pact with Johnson & Johnson
Premium
The Fly
Nanobiotix says LianBio enters NBTXR3 development pact with Johnson & Johnson
11M ago
LianBio confirms receipt of unsolicited proposal from Concentra Biosciences
PremiumThe FlyLianBio confirms receipt of unsolicited proposal from Concentra Biosciences
12M ago
LianBio price target lowered to $5 from $6 at BofA
Premium
The Fly
LianBio price target lowered to $5 from $6 at BofA
1y ago
LianBio reports Q3 EPS (22c), consensus (30c)
Premium
The Fly
LianBio reports Q3 EPS (22c), consensus (30c)
1y ago
LianBio partner Tarsus announces U.S. FDA approval of XDEMVY
PremiumThe FlyLianBio partner Tarsus announces U.S. FDA approval of XDEMVY
1y ago
LianBio partner NANOBIOTIX enters license agreement with JanssenJohnson & Johnson
Premium
The Fly
LianBio partner NANOBIOTIX enters license agreement with JanssenJohnson & Johnson
1y ago
LianBio announces clinical supply agreement with AstraZeneca
Premium
The Fly
LianBio announces clinical supply agreement with AstraZeneca
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100